Research and development of new drugs effective in the treatment of Trypanosoma cruzi infections are a real need for the 16 million people infected in the Americas. In a previous work, a quinoline derivative substituted by a 2-piperidylmethyl moiety showed to be active against Chagas disease and was considered a lead compound for further optimization. A series of ten analogous derivatives were tested against epimastigotes as a first approach. In view of their promising results, six of them were evaluated against the blood and intracellular replicative forms of the parasite in humans. Among them, compound 12 which possesses a 6-acetamidohexylamino substituent showed remarkable improvement in activity against epimastigotes, trypomastigotes an...
The progresses made in the field of drug design to combat tropical protozoan parasitic diseases, suc...
Therapies for human African trypanosomiasis and Chagas disease, caused by Trypanosoma brucei and Try...
Currently, only two drugs (i.e. benznidazole (BZN) and nifurtimox (NFX)) have been approved for the ...
Chagas disease is one of the main neglected diseases in the world, being endemic in 21 countries of ...
Chagas disease, caused by Trypanosoma cruzi parasite, was described thousands of years ago. Currentl...
As a part of our project aimed at developing new safe chemotherapeutic agents against tropical disea...
Background: Chagas disease affects about 7 million people worldwide. Only two drugs are currently av...
Probing multiple proprietary pharmaceutical libraries in parallel via virtual screening allowed rapi...
Aim: Chagas disease is a tropical disease caused by the hemoflagellate protozoan Trypanosoma cruzi. ...
Therapies for human African trypanosomiasis and Chagas disease, caused by Trypanosoma brucei and Try...
As a continuation of our project aimed at the search for new and safe chemotherapeutic and chemoprop...
Chagas disease is a neglected tropical disease caused by the flagellated protozoan Trypanosoma cruzi...
This research describes the exploration of a new scaffold with the potential to be developed in to a...
AbstractChagas disease is a neglected tropical disease caused by the flagellated protozoan Trypanoso...
As a part of our project pointed at the search of new safe chemotherapeutic and chemoprophylactic ag...
The progresses made in the field of drug design to combat tropical protozoan parasitic diseases, suc...
Therapies for human African trypanosomiasis and Chagas disease, caused by Trypanosoma brucei and Try...
Currently, only two drugs (i.e. benznidazole (BZN) and nifurtimox (NFX)) have been approved for the ...
Chagas disease is one of the main neglected diseases in the world, being endemic in 21 countries of ...
Chagas disease, caused by Trypanosoma cruzi parasite, was described thousands of years ago. Currentl...
As a part of our project aimed at developing new safe chemotherapeutic agents against tropical disea...
Background: Chagas disease affects about 7 million people worldwide. Only two drugs are currently av...
Probing multiple proprietary pharmaceutical libraries in parallel via virtual screening allowed rapi...
Aim: Chagas disease is a tropical disease caused by the hemoflagellate protozoan Trypanosoma cruzi. ...
Therapies for human African trypanosomiasis and Chagas disease, caused by Trypanosoma brucei and Try...
As a continuation of our project aimed at the search for new and safe chemotherapeutic and chemoprop...
Chagas disease is a neglected tropical disease caused by the flagellated protozoan Trypanosoma cruzi...
This research describes the exploration of a new scaffold with the potential to be developed in to a...
AbstractChagas disease is a neglected tropical disease caused by the flagellated protozoan Trypanoso...
As a part of our project pointed at the search of new safe chemotherapeutic and chemoprophylactic ag...
The progresses made in the field of drug design to combat tropical protozoan parasitic diseases, suc...
Therapies for human African trypanosomiasis and Chagas disease, caused by Trypanosoma brucei and Try...
Currently, only two drugs (i.e. benznidazole (BZN) and nifurtimox (NFX)) have been approved for the ...